News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Symphogen A/S and Open Monoclonal Technology, Inc. Announce Collaboration


10/15/2013 10:43:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Symphogen A/S, a private biopharmaceutical company with leadership in recombinant antibody mixtures for therapeutic use, and Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic animals for development of human therapeutic antibodies, today announced an alliance that provides Symphogen with unlimited access to OMT’s OmniRat® and OmniMouse® platforms. Symphogen will use its proprietary B cell-based antibody identification technology, Symplex™, and access the diverse immune repertoires generated in OMT’s transgenic animals to develop novel human therapeutic candidates.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES